Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction
- 1 August 1989
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 33 (8) , 1318-1325
- https://doi.org/10.1128/aac.33.8.1318
Abstract
Chromosomal multiple-antibiotic-resistant (Mar) mutants of Escherichia coli, selected on agar containing low concentrations of tetracycline or chloramphenicol, were 6- to 18-fold less susceptible to the fluoroquinolones than were their wild-type E. coli K-12 or E. coli C parental strains. The frequency of emergence of such mutants was at least, 1,000-fold higher than that of those selected by the fluoroquinolone norfloxacin directly. When Mar mutants, but not wild-type cells, were plated on norfloxacin, mutants resistant to high levels of norfloxacin (2 .mu.g/ml) appeared at a relatively high (.apprx.10-7) frequency. In addition to decreased amounts of OmpF, Mar mutants had other outer membrane protein changes and were four- to eightfold less susceptible to fluoroquinolones than was an ompF::Tn5 mutant lacking only OmpF. Accumulation of [3H]norfloxacin was more than threefold lower in the Mar mutants than in wild-type cells and twofold lower than in the OmpF-deficient derivative. These differences were not attributable to a change in the endogenous active efflux system for norfloxacin in E. coli. Norfloxacin-induced inhibition of DNA synthesis was threefhold lower in intact cells of a Mar mutant than in susceptible cells, but this difference was not seen in toluene-permeabilized cells. Insertion of Tn5 into marA (min 34.05 on the chromosome) led to a return of the wild-type patterns of norfloxacin accumulation, fluoroquinolone and other antimicrobial agent susceptibilities, and outer membrane protein profile, including partial restoration of OmpF. These findings together suggest that marA-dependent fluoroquinolone resistance is linked to decreased cell permeability, only part of which can be accounted for by the reduction in OmpF. Once mutated to marA, cells can achieve high levels of quinolone resistance at a relatively high frequency.This publication has 38 references indexed in Scilit:
- Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulationAntimicrobial Agents and Chemotherapy, 1989
- Endogenous active efflux of norfloxacin in susceptible Escherichia coliAntimicrobial Agents and Chemotherapy, 1988
- Norfloxacin resistance in a clinical isolate of Escherichia coliAntimicrobial Agents and Chemotherapy, 1987
- Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12Antimicrobial Agents and Chemotherapy, 1986
- Genetic and biochemical characterization of norfloxacin resistance in Escherichia coliAntimicrobial Agents and Chemotherapy, 1986
- Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coliAntimicrobial Agents and Chemotherapy, 1986
- The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroAntimicrobial Agents and Chemotherapy, 1985
- A unique mechanism regulating gene expression: translational inhibition by a complementary RNA transcript (micRNA).Proceedings of the National Academy of Sciences, 1984
- DNA TopoisomerasesAnnual Review of Biochemistry, 1981
- The ompB locus and the regulation of the major outer membrane porin proteins of Escherichia coli K12Journal of Molecular Biology, 1981